US Stock MarketDetailed Quotes

PBLA Panbela Therapeutics

Watchlist
  • 0.325
  • -0.005-1.52%
15min DelayClose Dec 20 16:00 ET
1.58MMarket Cap-0.01P/E (TTM)

About Panbela Therapeutics Company

Panbela Therapeutics, Inc. engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis. The firm’s product candidate, SBP-101, is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition (PMI), a metabolic pathway of critical importance in multiple tumor types. The company was founded by Michael T. Cullen, Jr. and Thomas X. Neenan on September 21, 2011 and is headquartered in Waconia, MN.

Company Profile

SymbolPBLA
Company NamePanbela Therapeutics
Founded2011
CEODr. Jennifer K Simpson, PhD
MarketPink Market
Employees8
Fiscal Year Ends12-31
Address712 Vista Boulevard,Suite 305
CityWaconia
ProvinceMinnesota
CountryUnited States of America
Zip Code55387
Phone1-952-479-1196
Websitehttp://www.panbela.com

Company Executives

  • Name
  • Position
  • Salary
  • Jennifer K Simpson
  • President and Chief Executive Officer
  • --
  • Dr. Michael T. Cullen, M.B.A.,M.D.
  • Executive Chairman of the Board, Chief Executive Officer and President
  • 72.50K
  • Susan Horvath
  • Vice President of Finance, Principal Accounting Officer, Chief Financial Officer, Secretary and Treasurer
  • 423.46K
  • Dr. Suzanne Gagnon, M.D.
  • Chief Medical Officer and Director
  • --
  • Michael T. Cullen
  • Chairman
  • --
  • Dan Donovan
  • Independent Director
  • --
  • Art Fratamico
  • Independent Director
  • --
  • Jeffrey S. Mathiesen
  • Independent Director
  • 81.50K
  • D. Robert Schemel
  • Independent Director
  • 57.50K
  • Robert Schemel
  • Independent Director
  • --
  • Jeff Mathiesen
  • Independent Director
  • --
  • Paul W. Schaffer
  • Independent Director
  • 30.00K
Heat List
US
Overall
Symbol
Price
% Chg

No Data